EUROFINS STRENGTHENS POSITION IN GLOBAL CLINICAL TRIALS MARKET WITH ACQUISITION OF FOCUS BIO-INOVA

A A

Eurofins Scientific strengthens its position in the global clinical trials market, and expands its testing services portfolio to the pharmaceutical and biotechnology industries with the acquisition of Focus Bio-Inova (FBI).
Euronext